Merck's Heart Stopping PR In Australia

The Center For Media and Democracy has:

Merck's Heart-Stopping PR in Australia

Source: The Australian, April 24, 2009

In Australia, the pharmaceutical company Merck is on trial. Australians who took the pain medication Vioxx allege that Merck and its Australian subsidiary, Merck Sharp & Dohme, "knew Vioxx increased the risk of heart attacks long before it voluntarily withdrew the drug from the market in 2004." Merck has paid $4.85 billion to U.S. Vioxx patients, but never admitted liability. As the Australian trial proceeds, Merck's public relations people from the Kreab & Gavin Anderson firm "follow journalists out of court, ask them what they are writing, hand out daily press releases and send 'background' emails they say should not be attributed to the company but which detail what they think are the 'salient points' from the evidence presented in court." The firm also phones reporters who write critical articles, to accuse "them of 'cherry-picking' the evidence and bombards newspapers with letters to the editor ... five were sent to The Australian in just seven days." Merck's Australian PR team, along with U.S. Merck spokeswoman Casey Stavropoulos, attends each day of the trial. The PR team sit near journalists covering the case, at one point even "looking over the shoulders of journalists at their notepads."

For The Full Monte see:

"Evidence And PR Spin Collide In Vioxx Courtroom Battle" in:

The Australian.

And if you're New here, see also:

Mental Health: Comes With FREE Cardiac Arrest